lcp
We have detected you are using Internet Explorer. To provide the best and most secure experience, please use a modern browser as we do not support Internet Explorer.

A quick look at the Australian osteoporosis guidelines

29 September 2017 - Dr Cathy Regan

Osteoporosis prevention, diagnosis and management in postmenopausal women and men over 50 years of age 2nd Edition

I was about to check out the new Australian osteoporosis guidelines when the new UK guidelines were announced in ANZAC week, so I decided to look at these as well.  Reassuringly, most recommendations are fairly similar. The Australian document is contributed to by Osteoporosis Australia and the RACGP and the UK one by about a dozen groups.  

At 98 pages, the new Australian 2nd edition guidelines are a bit longer than the previous 2010 version (and three times larger than the UK document).  Getting the balance right between usability and comprehensiveness is tricky. The more I read this document, the more I liked it although I did think that it was not entirely clear at times whether the outcome focus was osteoporosis or fractures/ falls.

What has changed

  • The status of evidence regarding the role of exercise (more encouraging but also more specific);
  • One new useful medication -  denosumab (prolia).  Unfortunately, like the bisphosphonates, it also has reports of osteonecrosis of the jaw and atypical femur fracture;
  • Some discussion re online tools for absolute fracture risk – giving options of FRAX and the GARVAN tool.  I tried both on myself and got slightly different results. The UK recommend FRAX specifically in their algorithm and have some interesting background discussion;
  • Some refining, based on ongoing evidence, of recommendations regarding calcium and vitamin D (see Recommendations 14, 27, 32). This includes delineating those who should be advised to take supplements if appropriate (frail and institutionalized elderly plus those on osteoporosis treatment with inadequate dietary calcium) and those who shouldn’t routinely be so advised (non-institutionalised). The guidelines note that not all studies support the recently reported association between supplemental calcium and increased myocardial infarction risk. They also note the report of an association between higher dose vitamin D and increased falls.

What I liked in the Australian guidelines

  • Four page summary of 42 recommendations graded A-D;
  • The chapters on special groups (elderly and those treated for cancer of breast and prostate);
  • Advice on how long to treat and when to reassess;
  • Background detail and evidence when you want it;
  • The algorithm is OK.

In summary

The algorithm distinguishes between patients with hip/vertebral fractures, other fragility fractures and no fractures. It then differentiates on age and BMD.  It includes use of clinical risk factors and a Risk Calculator – but further down the algorithm than in the UK document.

The introduction stated that only 20% of patients with minimal trauma fractures are adequately managed in general practice but the reference was from 2004.  Both new guidelines noted that the most effective system is to have Secondary Fracture Prevention programs with a coordinator after hospital admission.  I don’t think this happens universally in Australia.

Links

New Osteoporosis guidelines (Australia)

National Osteoporosis Guidelines Group (UK) 

Online tools: FRAX     

Garvan risk calculator 

Dr Cathy Regan
Dr Cathy Regan

Cathy (AM, BSocStud(hons), LittB, BMed, FRACGP, PhD) is a GP in Newcastle, NSW, who has been involved in medical education (at undergraduate, vocational and postgraduate level) for many years. Her PhD was in the area of frailty.

Get Medcast Plus

Become a member and get unlimited access to 100s of hours of premium education.

Learn more
Related News
Clinical AI in Practice: Ticker News interview with Dr Stephen Barnett

Medcast Education

Tune in for the 'Ticker News' interview, Ahron Young and Dr Stephen Barnett discuss how AI is changing clinical practice in real time, from improving access to evidence at the point of care to the risks of misinformation and AI hallucinations. Dr. Barnett also discusses how MedLuma supports trusted clinical decision-making and the role organisations play in shaping standards as AI becomes embedded in healthcare.

1 mins READ
FastTrack: practical tips for core symptom management in end-of-life care

Quality Use of Community Palliative Care Medicines Project

Brand icon

The National Core Community Palliative Medicines List consists of four medicines selected by expert consensus for symptom relief in end-of-life patients. This FastTrack covers the key principles of palliative medicine prescribing, including anticipatory prescribing, ethical considerations, and how to reduce medication errors. 30mins each RP and EA available.

6 mins READ
MedLuma launches to give Australian clinicians real-time answers while earning Continuing Professional Development (CPD) at the point of care

Medcast Education

Brand icon

Today, Medcast launched a new Australian AI-led healthcare technology platform, giving doctors and health organisations instant access to contextual answers from trusted clinical knowledge sources while earning Continuing Professional Development (CPD) as they work.

5 mins READ